Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

LAMISOPT EYE DROPS, SOLUTION 20 MG/ML

Approval Number

SIN14893P

Drug Name

LAMISOPT EYE DROPS, SOLUTION 20 MG/ML

Product Name

LAMISOPT EYE DROPS, SOLUTION 20 MG/ML

Approval Date

November 5, 2015

Registrant

LOTUS INTERNATIONAL PTE. LTD.

Licence Holder

LOTUS INTERNATIONAL PTE. LTD.

Regulatory Information

Registrant

LOTUS INTERNATIONAL PTE. LTD.

Licence Holder

LOTUS INTERNATIONAL PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

SOLUTION

Route of Administration

OPHTHALMIC

Medical Information

ATC Code

S01EC03

ATC Item Name

dorzolamide

Manufacturer Information

Pharmaceutical Manufacturer

LOTUS INTERNATIONAL PTE. LTD.

Manufacturers

Rafarm S.A

Active Ingredients

Ingredient Name

DORZOLAMIDE HYDROCHLORIDE 22.260 mg/ml EQV DORZOLAMIDE

Strength

20.000 mg/ ml

Drug MonographDorzolamide

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

LAMISOPT EYE DROPS, SOLUTION 20 MG/ML - HSA Approval | MedPath